INAB- In8bio, Inc.

INAB sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Fairbairn Emily	724.6K	$709.4K	-
CEO	Ho William Tai-Wei	206.0K	$201.7K	-
?	Brandt Peter C.	95.2K	$93.2K	-
COO	Rochlin Kate	80.0K	$78.3K	-
CFO	McCall Patrick	75.0K	$73.4K	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 17, 2022	Fletcher Aaron G.L.54	Director, 10% Owner	Buy	50,000	$1.93	$96,500.00	+1.1%	-20.2%	-42.4%
Aug 16, 2022	Fletcher Aaron G.L.54	Director, 10% Owner	Buy	1,773,684	$1.90	$3,369,999.60	+69.3%	-19.6%	-37.0%
Aug 16, 2022	Fairbairn Emily	Director, 10% Owner	Buy	789,473	$1.90	$1,499,998.70	+23.8%	-19.6%	-37.0%
Aug 16, 2022	Ho William Tai-Wei	President, CEO And CFO	Buy	26,315	$1.90	$49,998.50	+1.1%	-19.6%	-37.0%
Aug 16, 2022	Rochlin Kate	Chief Operating Officer	Buy	5,263	$1.90	$9,999.70	New	-19.6%	-37.0%
Aug 16, 2022	McCall Patrick	Chief Financial Officer	Buy	5,263	$1.90	$9,999.70	New	-19.6%	-37.0%
Aug 16, 2022	Goswami Trishna	Chief Medical Officer	Buy	2,631	$1.90	$4,998.90	New	-19.6%	-37.0%
Aug 16, 2022	Lamb Lawrence	EVP And CSO	Buy	526	$1.90	$999.40	+0.5%	-19.6%	-37.0%
Aug 16, 2022	Kreis Leslie W.45	Director, 10% Owner	Buy	1,773,684	$1.90	$3,369,999.60	+69.3%	-19.6%	-37.0%
Aug 16, 2022	Brandt Peter C.	Director	Buy	105,263	$1.90	$199,999.70	+136.3%	-19.6%	-37.0%